Impact of COVID-19 pandemic on patients with Parkinson's disease: A meta-analysis of 13,878 patients.

ABSTRACT:

Background

The clinical, neuropsychological, and socioeconomic factors affecting Parkinson's disease (PD) during COVID-19 pandemic across different populations have not been systematically studied. To address this, we conducted a meta-analysis of factors that impact the well-being of PD patients during the pandemic.

Methods

Medline and Embase were searched for articles published between 2020 and 2022. We conducted random-effects pooling of estimates and meta-regression.

Results

Twenty-seven studies involving 13,878 patients from America, Europe, Asia, and Africa were included. There is a high prevalence of decreased physical activity and exercise, and worsening motor and neuropsychiatric symptoms (17-56%). Patients in lower-income countries more frequently reported wo

SUBMITTER: Mai AS 

PROVIDER: S-EPMC9538738 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature